Slides in the "Myeloid neoplasms" Category

Acute myeloid leukemia with inv(16) (bone marrow – aspirate)

View Slide
This slide is part 2 of 2 in the series Acute myeloid leukemia with inv(16)

Clinical history:

43 year old woman with anemia and thrombocytopenia. WBC: 17,400 (28% blasts, 40% lymphocytes, 17% monocytes, 12% neutrophils, 3% eosinophils).

Cytogenetics:

inv(16) - This cytogenetic abnormality can be very subtle. FISH should be ordered on cases with morphologic features of inv(16) and reportedly normal karyotypes, as this finding may influence therapy.

inv(16) – This cytogenetic abnormality can be very subtle. FISH should be ordered on cases with morphologic features of inv(16) and reportedly normal karyotypes, as this finding may influence therapy.

Read more on Acute myeloid leukemia with inv(16) (bone marrow – aspirate)…

Acute myeloid leukemia with inv(16) (bone marrow – biopsy)

View Slide
This slide is part 1 of 2 in the series Acute myeloid leukemia with inv(16)

Clinical history:

43 year old woman with anemia and thrombocytopenia. WBC: 17,400 (28% blasts, 40% lymphocytes, 17% monocytes, 12% neutrophils, 3% eosinophils).

Acute myeloid leukemia with mutated NPM1 (morphologically FAB M5B)

View Slide

Clinical history:

37 y/o female. WBC 108.7, Hct 27.4, Plt 163. Molecular testing positive for NPM1 mutation and FLT3 ITD mutation.

Bone marrow aspirate:

Bone marrow aspirate - Maturing erythroid cells comprise >50% of the marrow population, and blasts comprise >20% of the non-erythroid population.

Bone marrow aspirate – Maturing erythroid cells comprise >50% of the marrow population, and blasts comprise >20% of the non-erythroid population.

Read more on Acute myeloid leukemia with mutated NPM1 (morphologically FAB M5B)…

Acute myeloid leukemia with t(8;21) (bone marrow – aspirate)

View Slide
This slide is part 2 of 2 in the series Acute myeloid leukemia with t(8;21)

Clinical history:

31 year old woman with anemia and thrombocytopenia. WBC: 9,400, no differential provided.

t(8;21) - This translocation involves RUNX1 (also known as AML1 or CBFA) at 21q22 and RUNX1T1 at 8q22. This finding defines AML, even in the absence of sufficient blasts in the marrow or PBL.

t(8;21) – This translocation involves RUNX1 (also known as AML1 or CBFA) at 21q22 and RUNX1T1 at 8q22. This finding defines AML, even in the absence of sufficient blasts in the marrow or PBL.

Read more on Acute myeloid leukemia with t(8;21) (bone marrow – aspirate)…

Acute myeloid leukemia with t(8;21) (bone marrow – biopsy)

View Slide
This slide is part 1 of 2 in the series Acute myeloid leukemia with t(8;21)

Clinical history:

31 year old woman with anemia and thrombocytopenia. WBC: 9,400, no differential provided.

Acute myeloid leukemia, not otherwise specified (FAB M1)

View Slide

Clinical history:

72 y/o female. WBC: 2.9, Hct: 24.2%, Plt: 29

Immunohistochemistry:

Acute myeloid leukemia, not otherwise specified (FAB M6A)

View Slide

Clinical history:

61 y/o male. WBC 1.7, HCT 27.6, PLT 91.

Immunohistochemistry:

Acute myeloid leukemia, pure erythroid leukemia variant (AML M6b)

View Slide

68 y/o male, 2 months status-post allogeneic BMT for AML.

Acute promyelocytic leukemia, classic variant (bone marrow – aspirate)

View Slide
This slide is part 2 of 2 in the series Acute promyelocytic leukemia, classic variant

Clinical history:

51 year old man with pancytopenia.

Cytogenetics:

t(15;17) - Fusion of the RARA (chr 17q12) and PML (chr 15q22) genes creates a fusion oncoprotein which defines APML, and mediates its responsiveness to all-trans retinoic acid (ATRA)

t(15;17) – Fusion of the RARA (chr 17q12) and PML (chr 15q22) genes creates a fusion oncoprotein which defines APML, and mediates its responsiveness to all-trans retinoic acid (ATRA)

Read more on Acute promyelocytic leukemia, classic variant (bone marrow – aspirate)…

Acute promyelocytic leukemia, classic variant (bone marrow – biopsy)

View Slide
This slide is part 1 of 2 in the series Acute promyelocytic leukemia, classic variant

Clinical history:

51 year old man with pancytopenia.

Blastic plasmacytoid dendritic cell neoplasm, involving bone marrow

View Slide
This slide is part 2 of 2 in the series BPDCN

Clinical history:

Female in her 60’s with pancytopenia and skin lesions. Bone marrow biopsy

Immunohistochemistry:

Chronic myelogenous leukemia, chronic phase

View Slide

Clinical history:

60 y/o female with WBC = 26

Bone marrow aspirate:

The majority of marrow cells are maturing or mature myeloids, with prominent populations of eosinopils and basophils also present.

The majority of marrow cells are maturing or mature myeloids, with prominent populations of eosinopils and basophils also present.

Read more on Chronic myelogenous leukemia, chronic phase…

Chronic myelogenous leukemia, chronic phase (2)

View Slide

Clinical history:

42 year old man with fatigue, abdominal pain, and leukocytosis. WBC: 365,000. HCT: 18%. PLT: 568,000.

Cytogenetics:

t(9;22) - This translocation fuses portions of the genes BCR (22q11.2) and ABL (9q34), usually producing the p210 BCR-ABL fusion protein.

t(9;22) – This translocation fuses portions of the genes BCR (22q11.2) and ABL (9q34), usually producing the p210 BCR-ABL fusion protein.

Read more on Chronic myelogenous leukemia, chronic phase (2)…

Chronic myeloid neoplasm with FGFR1 rearrangement

View Slide
This slide is part 1 of 2 in the series Myeloid and lymphoid neoplasms with FGFR1 rearrangement

52 y/o female with diffuse lymphadenopathy, hepatosplenomegaly, and peripheral eosinophilia

Chronic myeloid neoplasm with PDGFRA rearrangement

View Slide
This slide is part 1 of 2 in the series Myeloid and lymphoid neoplasms with PDGFRA rearrangement

29 y/o male with inguinal lymphadenopathy and peripheral eosinophilia

Histiocytic sarcoma

View Slide

67 y/o female with mass in T9 vertebra

Myelodysplastic syndrome with isolated del(5q) (Bone marrow – biopsy)

View Slide

Clinical history:

55 year old woman with anemia. WBC: 11,500. HCT: 26.2% PLT: 262,000.

Cytogenetics:

Isolated del(5q) – This cytogenetic abnormality defines MDS with isolated del(5q), and predicts responsiveness to lenalidomide.

Read more on Myelodysplastic syndrome with isolated del(5q) (Bone marrow – biopsy)…

Primary myelofibrosis (fibrotic stage)

View Slide

Clinical history:

60 year old woman with pancytopenia and splenomegaly. JAK2 mutation present.

Refractory anemia with ring sideroblasts

View Slide

Bone marrow aspirate stains:

Residual/relapsing AML within a hypocellular marrow

View Slide

21 y/o female with history of AML, 6 months post-allogeneic BMT, now with dropping counts: WBC 0.6, Hct 25.5%, Plt 25. (Feathered edge of bone marrow aspirate is best area, also circled area of touch prep.)

Read more on Residual/relapsing AML within a hypocellular marrow…

Systemic mastocytosis

View Slide

37 y/o male with urticaria. Bone marrow biopsy.